Letter to the Editor

18. Kabir AA, Whelton PK, Khan MM et al., Association of symptoms of depression and obesity with hypertension: the Bogalusa Heart study. Am J Hypertens 2005; 19(6): 639–645. 19. Schutte R, Schutte AE, Huisman HW, van Rooyen JM, Malan NT, Péter S, et al. Blood glutathione and sub-clinical atherosclerosis in African men: the SABPA study. Am J Hypertens 2009; 22: 1154–1159. 20. Giuseppe M, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J 2007; 28: 1462–1532. 21. World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects. World Medical Association online 2005 Available at: http://www.wma. net/e/policy/ b3.htm. Accessed November 9, 2008. 22. Obrist PA. Cardiovascular Psychophysiology: A Perspective. London: Plenum Press, 1981. 23. World Health Organization 2003. The Global Physical Activity Questionnaire (GPAQ). Available at: http://www.who. int/entitty/chp/steps/ resources/GPAQ.htm Accessed: November 7, 2008. 24. Jackson G. The General Health questionnaire. Occup Med 2007; 57(1): 79. 25. Stapelberg R. Psychometric characteristics of the Cope and SACS in the Setswana-speaking South African group (MA). Potchefstroom University, Potchefstroom. 1999: 200. 26. Goldberg DP, Gater R, Sartorius TB, et al. The validity of two of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997; 27: 191–197. 27. Marfell-Jones M, Olds T, Stewart A, et al. International standards for anthropometric assessment. ISAK: International Society for the Advancement of Kinanthropometry, 2006: 58–87. 28. American College of Sports Medicine (ACSM). Guidelines for Exercise Testing and Prescription. 7th edn. Philadelphia: Lippincott Williams & Wilkins, 2006. 29. Heil DP. Predicting activity energy expenditure using the Actical Activity Monitor. Res Q Exercise Sport 2006; 77(1): 64–80. 30. Ang DSC, Lang CC. The prognostic value of the ECG in hypertension: where are you now? J Hum Hypertens 2008; 22: 460–467. 31. Riolo SA, Nguyen TA, Greden JF, et al. Prevalence of depression by race/ethnicity: findings from the National Health & Nutrition Examination study III. Am J Public Hlth 2005; 95(6): 998–1000. 32. Brownhill S, Wilhelm K, Barclay L, et al. ‘Big build’: hidden depression in men. Aust N Z J Psychiat 2005; 39(10): 921–931. 33. Appels A. Mental precursors of myocardial infarction. Br J Psychiat 1990; 156: 465–471. 34. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic values of a new electrocardiographic method for the diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 1998; 31: 383–390. 35. Sundström J, Lind L, Arnlöv J, et al. Echocardiographic and echocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001; 103: 2346–2351. 36. Farmer A. Medical disorders in people with recurrent depression. Br J Psychol 2008; 192: 351–355. 37. Remme WJ. The sympathetic nervous system and ischemic heart disease. Eur Heart J 1998; 19(F): 62–71. 38. Reynolds RM, Walker BR, Syddall HE, et al. Altered control of cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 1999; 10: 117–139. 39. Gold SM, Dziobek I, Rogers K. Hypertension and hypothalamopituitary-adrenal axis hyperactivity affect frontal lobe integrity. J Clin Endocrinol Metab 2005; 90(6): 3262–3267. 40. Rieff M, Schwartz S, Northridge M. Relationship of depressive symptoms to hypertension in a household survey in Harlem. Psychosom Med 2001; 63: 711–721. 41. Dimsdale JE. Symptoms of anxiety and depression as a precursor to hypertension. J Am Med Assoc 1997; 277: 574–575. 42. Jonas BS, Frank P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Arch Fam Med 1997; 6(1): 43–49.